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Background. This study was designed to evaluate the incidence of acute mountain sickness (AMS) occurring on diﬀerent climbing
routes on Mount Damavand and the eﬀect of beginning time of ascent in Iranian trekkers. Methods. This study was a descriptive
cohort investigation, performed in summer 2007. All trekkers who ascended Mount Damavand from northern, western, eastern,
and southern paths and passed 4200m altitude were included in the study. Two questionnaires were completed for each
trekker (personal information and Lake Louise score questionnaire). Multiple logistic regression analysis was used to explore
the independent predicting variables for AMS. Results. Overall incidence rate of AMS was 53.6%. This rate was the highest in
south route (61.5%) (P<0.001). There was no diﬀerence in the incidence of AMS on other paths. AMS history, AMS history on
Damavand,thebeginningtimeofclimbing,sleepingat4200maltitude,andhomealtitudehadsigniﬁcanteﬀectonAMSincidence,
but by multiple logistic regression analysis south route and AMS history on Mount Damavand had positive eﬀect on incidence of
AMS (P = 0.019 and P<0.001). Conclusion. The path and the beginning time of ascent can aﬀect incidence of AMS. The risk of
occurrence of AMS was 1.9 times as large for trekkers who ascended from southern route.
1.Introduction
Acute mountain sickness (AMS) is a disorder which is seen
in ascent to altitudes higher than 3000 meters. It is a clinical
syndrome with headache and one or more other symptoms
including gastrointestinal symptoms (poor appetite, nausea,
vomiting), fatigue and/or weakness, dizziness/lightheaded-
ness, and sleep disturbances [1, 2]. Its diagnosis is based
on environmental symptom questionnaires, Hackett or Lake
LouiseAMSscore[3,4].Severalstudiesindiﬀerentcountries
havebeendonesofar,andincidencerateshavebeenreported
from 25% to 69% [2, 5–11]. Some eﬀective factors have
been considered in several studies, such as change of altitude
related to residence altitude [3, 5, 11], speed of mountain
climbing [1, 2, 11], very low and very high range of ages [5,
12], positive history of mountain sickness [8, 11], beginning
mountainclimbingatnight[11],sleepinaltitudesmorethan
3h o u r si na l t i t u d e[ 1], and water and ﬂuid intake [13].
However, the relation of some factors like age and gender to
the incidence of the disease is in doubt.
MountDamavandhasfourmainpathsformountaineers’
ascent. In our previous study, the incidence rate of disease
was seen in more than 60% of mountaineers who ascend
from the south [11]. Iranian expert mountaineers believe
thatascentfromsouthernpathisaccompaniedbyhigherdis-
ease occurrence, but there is no documented data for this
belief. On the other hand, some of the trekkers plan the
beginning of mountain climbing at night. In the literature
review, we did not ﬁnd any investigation on beginning of
ascending time (except our previous study [11]) and eﬀect of
path on incidence of AMS in other altitudes. So we designed
this study for evaluating the incidence of AMS in diﬀerent2 Neurology Research International
Table 1: Lake Louise score for detecting acute mountain sickness.
Self-report questionnaire
1. Headache
0 No headache
1 Mild headache
2 Moderate headache
3 Severe headache, incapacitating
2. Gastrointestinal symptoms
0 No gastrointestinal symptoms
1P o o ra p p e t i t eo rn a u s e a
2 Moderate nausea or vomiting
3 Severe nausea and vomiting,
incapacitating
3. Fatigue and/or weakness
0 Not tired or weak
1 Mild fatigue/weakness
2 Moderate fatigue/weakness
3 Severe fatigue/weakness, incapacitating
4. Dizziness/lightheadedness
0 Not dizzy
1 Mild dizziness
2 Moderate dizziness
3 Severe dizziness, incapacitating
5. Diﬃculty sleeping
0 Slept as well as usual
1 Did not sleep as well as usual
2 Woke many times, poor nights sleep
3 Could not sleep at all
Clinical assessment
6. Change in mental status
0 No change in mental status
1 Lethargy/lassitude
2 Disorientated/confused
3 Stupor/semiconscious
7. Ataxia (heel-toe-walking)
0N oa t a x i a
1 Maneuvers to maintain balance
2 Steps oﬀ line
3F a l l sd o w n
4 Can not stand
8. Peripheral edema
0 No peripheral edema
1 Peripheral edema in one location
2 Peripheral edema in two or more locations
The Self-report score above (questions 1–5) stands alone, and this is recommended for general mountain travellers.
Additional observations are sometimes used by researchers.
The clinical assessment score (questions 6–8) can be added to the self-report score, in which case, in the context of a recent rise in altitude, a score of 5 or
more would be taken as AMS.
AMS: altitude rise and headache and at least 1 other symptom (from Q1–5) and a total score of 5 or more (Q1–8).
paths of Mount Damavand and the eﬀect of beginning time
of ascent on AMS incidence in Iranian trekkers.
2.SubjectsandMethods
This study was a descriptive cohort study which was per-
formed on trekkers of Mount Damavand during 8 weekends
insummer2007.MountDamavand,Iran’shighestmountain
is located in the Alborz mountain range and it has special
characteristic such as dormant volcano and single peak.
All trekkers who climb over 4200m were included in this
study. Two questionnaires were completed for each trekker.
These questionnaires were used in our previous study in
Damavand. The ﬁrst questionnaire was related to personal
information and ascent characteristics (including sex, age,
and home altitude, medical history, past history of AMS,
beginning time of mountain climbing, number of acclimati-
zation programs before this trekking, and duration of sleep-
ing at over 4200m), and the second questionnaire was Lake
Louise score questionnaire. AMS was deﬁned as a Lake Lou-
ise score more than 5 (Table 1)[ 3]. Sleeping more than 3
hours was considered as a risk factor for AMS. All of the
questionnaires were completed by interview after taking in-
formed consent. Interviewers were trained physicians when
trekkers came back to the camps of 4200m.
According to our previous study [11], sample size was
calculated to be 280 trekkers in all four paths (70 trekkers for
each path). In this period, all men and women who ascendedNeurology Research International 3
Table 2: The incidence rate of AMS in trekkers in each path of Mount Damavand.
Path Point of starting No of climber Incidence rate of AMS P value
South 2800 143 61.5%
North 2350 73 38.4% <0.001
West 2900 64 45.3%
East 2950 71 32.4%
Mount Damavand from northern, western, eastern, and
southern paths and passed 4200m altitude were included
in the study. Exclusion criteria included mountaineers who
had used drugs for AMS prevention (acetazolamide, dexam-
ethasone, or aspirin) or individuals who could not ascend
to the top because of climbing-related injuries. Convenient
sampling was done with the presence of research team at the
altitudeofabout4200 metersindiﬀerentpaths.Accordingto
our previous experience [11], the participants were divided
into three groups by their age, under 15y, 16–50y, and
over 50y. Trekkers were divided into 3 groups based on the
number of ascents they had made to altitudes above 4000m
in the last 6 months: experienced (more than 3 ascents),
semiexperienced (1-2 ascents), and inexperienced (less than
1 ascents).
ThisstudywasapprovedbyresearchcommitteeofSports
Medicine Research Center and ethics committee of Tehran
University of Medical Sciences.
The collected data were analyzed by SPSS (version 15).
Qualitative data were summarized as frequencies, whereas
continuous data were expressed as mean and standard devi-
ation. Categorical variables were analyzed with the chi-
square and Fisher exact test and numerical variables were
analyzed with the independent t-test. Bonferroni correction
wasusedformultiplecomparisonsbetweenthegroups.Mul-
tiple logistic regression analysis was used to explore the inde-
pendent predicting variables for AMS. For inferential pur-
pose, 95% conﬁdence interval was presented for the esti-
mated eﬀects (e.g., odds ratio). A 2-sided P value less than
0.05 was considered signiﬁcant.
3. Results
From360completedquestionnaires,9personswereexcluded
because of drug utilization and none of the studied persons
was injured and ﬁnally 351 persons were studied (including
300 male and 51 female Mountaineers). Mean age of partici-
pants was 35.08 years, and its range was from 12 to 69 years.
AMSoccurredin188trekkers,sotheoverallincidencerateof
AMS was 53.6%. The mean age of patients and nonpatients
were35.3and34.8years,respectively.Thisdiﬀerencewasnot
statistically signiﬁcant (P = 0.9). The incidence rate under
15y, 16–50y, and over 50y was 33.8%, 48.5%, and 44.2%,
respectively, but these diﬀerences were also not statistically
signiﬁcant(P = 0.7).Forty-ninepercentofmaleparticipants
and 41.2% of female participants were aﬀected, and this
diﬀerence was also not statistically signiﬁcant (P = 0.2).
The highest incidence rate of AMS was in southern path.
Table 2 showsthenumberofmountaineersandtheincidence
Table 3: Comparison between risk estimation of AMS incidence in
diﬀerent paths.
Diﬀerent path P value∗ OR (odds ratio) 95% CI∗∗
South to North <0.001 2.57 1.44–4.59
South to East <0.001 3.33 1.82–6.25
South to West 0.022 1.93 1.06–3.57
West to East 0.09 1.73 0.86–1.48
North to West 0.3 0.75 0.61–1.49
North to East 0.4 1.30 0.65–2.56
∗P values are adjusted by Bonferroni correction.
∗∗95% conﬁdence interval for odds ratio.
of AMS in each path. The diﬀerence between the incidences
among diﬀerent paths was highly signiﬁcant (P<0.001).
Although AMS incidence was signiﬁcantly higher in south-
ern path in comparison to others, there was no diﬀerence be-
tween the incidences of AMS in other paths (Table 3). Seven-
teen to thirty-one percent of trekkers in north, west, and east
paths were inexperienced, while this percent in south path
was about 47%. There is no signiﬁcant diﬀerence between
experience of trekkers in north, west, and east paths, but
this variable was signiﬁcantly diﬀerent in south path in
comparison to others (P = 0.01).
The minimum incidence of the disease as it is shown by
Table 4 was in individuals who started climbing between 6
and 12 AM (P = 0.02), but the time of mountain top arrival
had no inﬂuence on the disease incidence (P = 0.4). Occur-
rence of disease was greater in persons who did not have
acclimatization. This diﬀerence tended to be statistically sig-
niﬁcant (P = 0.06). In any case the number of acclimatiza-
tion programs, inﬂuencing the incidence rate, decreases. The
mean acclimatization programs in nonpatients were greater
or equal to 2.17 (SD = 1.46), while in patients were less or
e q u a lt o1 . 7 6( S D= 1.25), and statistically signiﬁcant (P =
0.025,CI=0.05–0.76).Cigarettesmokingandpositivefamily
history of AMS had no statistically signiﬁcant inﬂuence on
the incidence of the disease (P = 0.5 for each one).
Table 4 shows the incidence of disease predictors in the
univariate analysis.Table 5 showsmultiplelogistic regression
models to identify determinants of AMS. Initial model in-
cludes beginning time of mountain climbing, sleeping at
4200m altitude, home altitude, AMS history, and AMS his-
tory in Damavand. Multiple logistic regression analysis
reveals that the southern path and AMS history on Mount
Damavand increases the incidence of AMS in Damavand
(P = 0.019 and P<0.001, resp.). The risk of AMS4 Neurology Research International
Table 4: Variables associated with incidence of disease in the univariate analysis.
Variable Deﬁnition
AMS
P value∗
Positive Negative
Beginning time of ascent†
00:00–05:59
06:00–11:59
12:00–17:59
106 (60.6%)
70 (44.9%)
10 (52.6%)
68 (39.4%)
86 (55.1%)
8 (47.4%)
0.02
Sleeping at 4200 m altitude Positive
Negative
139 (45.3%)
27 (67.5%)
168 (54.7%)
13 (32.5%) 0.01
Home altitude Less than 1000m
More than 1000m
33 (61.1%)
132 (44.9%)
21 (38.9%)
162 (55.1%) 0.03
AMS history Positive
Negative
79 (55.2%)
88 (42.7%)
64 (44.8%)
118 (57.3%) 0.02
AMS history in Damavand Positive
Negative
75 (56.4%)
61 (36.5%)
58 (43.6%)
106 (63.5%) 0.001
∗Based on chi-square or Fisher exact test.
†There was just 1 participant who trekked between 18:00 and 11.59PM. He did not meet criteria of AMS, so we omitted him from analysis of this item.
Table 5:Multiplelogisticregressionmodeltoidentifydeterminants
of AMS.
Variable P value OR
95.0% CI for OR
Lower Upper
Path 0.019 1.90 1.11 3.26
AMS history in
Damavand <0.001 2.90 1.70 4.94
Initial model includes beginning time of ascent, sleeping at 4200m altitude,
home altitude, AMS history, AMS history in Damavand, and number of
ascents during previous 6m.
occurrence for trekkers who ascended from southern path
was 1.9 (CI=1.1–3.3) (Table 5).
4. Discussion
The main goal of this study was assessment of acute moun-
tain sickness incidence in diﬀerent paths of Damavand. Ac-
cording to our review, this is the ﬁrst study to evaluate eﬀect
of ascending path on AMS. The novel ﬁnding of this study
is that the incidence of AMS had association with ascending
route.
Asawhole,theincidencerateofAMSinthisstudyandin
all four paths was the highest among studies on AMS. In pre-
vious studies, the incidence of AMS is reported as 68% in the
study of mountaineers who climbed over 4200m in Hima-
laya [5] and 69% in professional astronomy staﬀ on Mauna
Kea [9]. In other studies at about 4800m or less which were
mainlyonAlpsandRockymountainsclimbers,theincidence
rate was lower than 40% [2, 5, 10, 14, 15]. As a whole, high
incidence rate of AMS in our study can be due to speciﬁc
characteristicsofMountDamavandorgeneticcharacteristics
of Iranian trekkers. The incidence of AMS was 10.4 to 34.5%
inastudyonMountTochal(anothermountainintheAlborz
range at 3450m) [15, 16].
In our previous study which was also reported on the
southern path of Damavand, incidence rate was 60.8% [11].
Our ﬁndings in this study showed that the incidence rate
of AMS was unequal in diﬀerence routes of mountain. This
ﬁnding conﬁrms the expert climbers’ idea about Damavand.
They believe that southern route causes higher rate of AMS.
Our study showed that AMS in southern path climbers was
signiﬁcantly higher than any other path, but there is not sig-
niﬁcant diﬀerence among any other paths. By multiple logis-
tic regression analysis, we showed southern path has positive
eﬀect on AMS incidence rate.
A hypothesis is that the individual characteristics of
Damavand in southern path (such as higher substantial
amount of malodorous sulfur compounds and high-steep
path in comparison with other paths) have caused this
[11]. Some authors suggest that sulfur has a positive eﬀect
on incidence of AMS [17]. The expert climbers that have
a prolong experience on ascending Damavand conﬁrm it.
Furthermore, a study on sulfur concentration in each path
of Mount Damavand needs to be done. On the other hand,
the southern route has less distance and it is the easiest route,
so trekkers can ascent faster and less-experienced trekkers
select this rout for ascending (as it is seen in Section 3).
Fastermountainclimbingandhigher-inexperiencedtrekkers
in south route can be other factors that inﬂuence higher rate
of AMS in this route.
Often trekkers believe the best time for trekking on the
Damavand is at the early morning (before 4AM), and this
time is accompanied by lower AMS rate. We tested this
hypothesisinthisstudy.Accordingtoourﬁndings,thelowest
incidenceofAMSwasintrekkerswhostartclimbingbetween
6AMand12MD.Itwassimilarwithourﬁndingsinprevious
study [11]. This ﬁnding needs more investigation in the
future and in other mountain tops. If it was found in the
Damavand, it may be due to environmental factors (such as
the higher concentration of sulfur during night period), and
if it was found in other mountains, it may be due to personal
character (such as fatigue at the night). Exercise in a fatigue
personisaccompaniedbyexacerbationofarterialhypoxemia
[18].
Meaningful inﬂuence of positive past history of AMS on
frequent AMS has been reported in other studies [5, 10,
11]. Inﬂuence of physiologic and genetic characteristics ofNeurology Research International 5
individual suﬀering from AMS are guessed as important fac-
tors [19, 20]. However, in this study there was an association
between AMS and positive history of AMS in the univariate
analysis, but not in multiple logistic regression analysis. On
the other hand, AMS history in Damavand was a positive
factor for AMS occurrence in both the univariate and mul-
tiple logistic regression analyses. This ﬁnding conﬁrms the
similar ﬁnding in our previous study [11], and the Iranian
expert trekkers think that there is a speciﬁc character in
Mount Damavand which is such as high sulfur gas concen-
tration in the air.
Similar to our previous study and other studies, there
was no relation between sex, age, and smoking and incidence
rate of AMS [1, 11, 21]. However, a higher incidence of AMS
has been reported in children and a lower rate in the elderly
[1, 5, 22, 23]. The ﬁnding of this study in relation to the role
of residence altitude in the incidence rate of the disease was
the same as other studies [5, 11]. Speed of mountain climb-
ing was an eﬀective factor in the occurrence of AMS in other
studies [1, 2, 22, 24], but in our study there was no meaning-
ful diﬀerence between mean climbing time in patients and
healthy groups.
Some study showed the eﬀect of acclimatization in pre-
vention of AMS [25]. Similarly, in our study we found that
acclimatization programs cause more decrease in AMS.
In this study like the previous one, there is a signiﬁcant
inverted relationship between sleeping in altitudes and the
occurrence of AMS [11]. Fatigue due to short time of sleep-
ing may be the reason for higher AMS, while insomnia is
a symptom of AMS. However, the average time of sleep in
aﬀected and nonaﬀected individuals had no statistically sig-
niﬁcant diﬀerence. It seems that other factors such as expe-
rience of climbers or fatigue aﬀect this ﬁnding. In our
study, we did not ﬁnd any association between sleep in
altitude and incidence of AMS in multiple logistic regression
analysis.
None of the factors such as sleeping at 4200m altitude,
home altitude, and AMS history was signiﬁcant predictors
of AMS (southern path as a signiﬁcant predictor of AMS
doubles its risk in comparison to other routes).
5. Strength andLimitation
Our study was performed on Mount Damavand with the
characteristicssuchasdormantvolcano,singlepeak,andsul-
fur odors especially on south route. On the other hand, we
did not ﬁnd other study in this mount except our previous
study. Moreover, no previous studies have evaluated the in-
ﬂuence of the time of beginning mountain climbing on
occurrence of AMS.
Our study has some limitations. The incidence of AMS
above 4200m, this rate might be higher if climbers/trekkers
who started climbing but turned around below 4200m were
included. In addition, we did not consider the rate of ascend-
ing in our subjects. It was diﬀerent in diﬀerent routes due to
distance or diﬃcult pathway. These items could inﬂuence the
incidence of AMS.
6. Conclusion
Although several known factors cause AMS, there are also
some unknown factors which do the same. Besides other
factors, the path and the beginning time of climbing can
aﬀect the incidence of AMS. The risk of AMS occurrence was
doubled for trekkers who ascended from southern path. In
our study AMS history in general, AMS history on Dama-
vand in particular, the beginning time of climbing, sleeping
at 4200m altitude, and home altitude had signiﬁcant eﬀect
on AMS incidence.
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